Abstract
Potent and noncovalent inhibitors of caspase-1 were produced by incorporating a secondary amine (reduced amide) isostere in place of the conventional electrophile (e.g., aldehyde) that normally confers high potency to cysteine protease inhibitors. Benzyl- or cyclohexylamines produced potent, reversible, and competitive inhibitors that were selective for caspase-1 (e.g., K(i) = 47 nM) over caspases 3 and 8 with minimal cytotoxicity. Unlike most cysteine protease inhibitors, these compounds do not react covalently and indiscriminately with thiols.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amines / chemical synthesis
-
Amines / chemistry
-
Amines / pharmacology*
-
Benzene / chemistry
-
Caspase 1 / chemistry
-
Caspase 1 / metabolism
-
Caspase Inhibitors*
-
Cell Survival / drug effects
-
Cyclohexylamines / chemical synthesis
-
Cyclohexylamines / chemistry
-
Cyclohexylamines / pharmacology
-
Cysteine Proteinase Inhibitors / chemical synthesis
-
Cysteine Proteinase Inhibitors / chemistry
-
Cysteine Proteinase Inhibitors / pharmacology*
-
HT29 Cells
-
Humans
-
Kinetics
-
Models, Chemical
-
Models, Molecular
-
Molecular Structure
-
Protein Binding
-
Protein Structure, Tertiary
Substances
-
Amines
-
Caspase Inhibitors
-
Cyclohexylamines
-
Cysteine Proteinase Inhibitors
-
Caspase 1
-
Benzene